NRAS c.54A>G ;(p.A18=)

Variant ID: 1-115258728-T-C

NM_002524.4(NRAS):c.54A>G;(p.A18=)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients.

Cell Stem Cell
de Kanter, Jurrian K JK; Peci, Flavia F; Bertrums, Eline E; Rosendahl Huber, Axel A; van Leeuwen, Anaïs A; van Roosmalen, Markus J MJ; Manders, Freek F; Verheul, Mark M; Oka, Rurika R; Brandsma, Arianne M AM; Bierings, Marc M; Belderbos, Mirjam M; van Boxtel, Ruben R
Publication Date: 2021-10-07

Variant appearance in text: NRAS: A18A
PubMed Link: 34496298
Variant Present in the following documents:
  • Main text
View BVdb publication page



Integrative omics analyses broaden treatment targets in human cancer.

Genome Medicine
Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyö, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L
Publication Date: 2018-07-27

Variant appearance in text: NRAS: A18A
PubMed Link: 30053901
Variant Present in the following documents:
  • 13073_2018_564_MOESM2_ESM.xlsx, sheet 2
View BVdb publication page